ArticleAdvances in therapy2025

Cost-Consequences of Adding Gliclazide Modified Release to Metformin in Patients with Uncontrolled Type 2 Diabetes in the United Arab Emirates.

Mohamed Farghaly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.